Academic Commons

Articles

The Need for Vigilance in the Marketing of Genomic Tests in Psychiatry

Klitzman, Robert L.

Recently, several for-profit companies have been developing and marketing genetic tests to psychiatrists, yet the clinical utility of these is not always clear, posing several concerns. Important genomic research is continuing, and genomic tests potentially can help with both the diagnosis and treatment of many patients. Yet it is important that clinicians be aware of potential limitations of tests that may be marketed to them.

Files

  • thumnail for Klitzman_The need for vigilance in the marketing of genomic tests in psychiatry.pdf Klitzman_The need for vigilance in the marketing of genomic tests in psychiatry.pdf application/pdf 22.2 KB Download File

Also Published In

Title
The Journal of Nervous and Mental Disease
DOI
https://doi.org/10.1097/NMD.0000000000000372

More About This Work

Academic Units
Psychiatry
Published Here
July 27, 2020